US Patent 8481031 Methods and compositions using Klotho-FGF fusion polypeptides
Patent 8481031 was granted and assigned to Novartis on July, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 9 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Nov, 2023
Golden AI
Edits made to:
Article (+168 characters)
Article
Patent abstract
The present invention is directed to fusion polypeptides comprising Klotho protein or an active fragment thereof and FGF23 or an active fragment thereof.
Edits on 7 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08481031 Methods and compositions using Klotho-FGF fusion polypeptides US Patent 8481031 Methods and compositions using Klotho-FGF fusion polypeptides
Infobox
Patent Number
0848103100
Patent Number
848103100
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084810310
Date of Patent
July 9, 2013
0Patent Application Number
123609700
Date Filed
January 28, 2009
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084810310
Date of Patent
July 9, 2013
0Patent Application Number
123609700
Date Filed
January 28, 2009
0Patent Primary Examiner
Edits on 17 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08481031 Methods and compositions using Klotho-FGF fusion polypeptides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08481031
Date of patent
July 9, 2013
Patent application number
12360970
Date Filed
January 28, 2009
Patent primary examiner
Find more entities like US Patent 8481031 Methods and compositions using Klotho-FGF fusion polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
